Clinical trial
A Phase II, Randomized, Double-Blind, Parallel Group, Acyclovir-Controlled Study to Evaluate ZEP-3 Ointment for the Treatment of Cold Sores (Herpes Labialis).
NCT02483182 is registered in ClinicalTrials.gov with Shulov Innovate for Science Ltd. 2012 as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Randomized, Double-Blind, Parallel Group, Acyclovir-Controlled Study to Evaluate ZEP-3 Ointment for the Treatment of Cold Sores (Herpes Labialis).
- Lead sponsor
- Shulov Innovate for Science Ltd. 2012
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- June 24, 2018
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.